Search Results - "STEWART-JONES GUILLAUME"

PubPharm (340)

101

RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE

in: Europäisches Patentamt | 2023

by KWONG PETER | STEWART-JONES GUILLAUME | GORMAN JASON | +8

102

MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE

in: Europäisches Patentamt | 2023

by GRAHAM BARNEY | STEWART-JONES GUILLAUME | LOOMIS REBECCA J

103

PREFUSION PIV F IMMUNOGENS AND THEIR USE

in: Europäisches Patentamt | 2023

by ZHANG BAOSHAN | TSYBOVSKY YAROSLAV | XU KAI | +12

104

Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice

in: Nature medicine | 2023

by Scheaffer, S. | Lee, D. | Whitener, B. | +20

UpdateOf: bioRxiv. 2022 Sep 13:2022.09.12.507614. doi: 10.1101/2022.09.12.507614. - PMID 36263060

105

PAN-HUMAN CORONAVIRUS VACCINES

in: Europäisches Patentamt | 2023

by STEWART-JONES GUILLAUME

106

PAN-HUMAN CORONAVIRUS VACCINES

in: Europäisches Patentamt | 2023

by STEWART-JONES GUILLAUME

107

PAN-HUMAN CORONAVIRUS DOMAIN VACCINES

in: Europäisches Patentamt | 2023

by STEWART-JONES GUILLAUME

108

SARS-COV-2 mRNA domain vaccine

in: Europäisches Patentamt | 2022

by STEWART-JONES GUILLAUME | ELBASHIR SYED MAHAGOOB | ANDREA CARFI | +1

109

SARS-COV-2 mRNA domain vaccine

in: Europäisches Patentamt | 2022

by STEWART-JONES GUILLAUME | ELBASHIR SYED MAHAGOOB | ANDREA CARFI | +1

110

Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice

in: bioRxiv.org | 2022

by Wu, K. | Choi, A. | Koch, M. | +22

[1]
« Prev
6
7
8
9
10
11
12
13
14
15
16
Next »
[34]